Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

Rare diseases: meeting the challenge

Problems with regulating orphan drugs

- PMLiVE

FDA panel backs Puma’s breast cancer drug, with reservations

Side effects concerns could see medicines limited

- PMLiVE

Pfizer gets FDA panel recommendation for biosimilar EPO

Product could be the first direct competitor to Epogen and Procrit in the US

- PMLiVE

The false economy of following the leader

How can companies in the sector shake things up?

PEGASUS UNVEILS NEW BRAND IDENTITY AS IT CELEBRATES A YEAR AS PART OF ASHFIELD

Pegasus, an Ashfield company, part of UDG Healthcare plc, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by...

Inizio

- PMLiVE

Recordati acquires AstraZeneca blood pressure brands

Italian pharma firm obtains Seloken and Logimax

- PMLiVE

MSD probed by UK for blocking Remicade biosimilars

Pharma giant’s discount scheme for infliximab labelled ‘anti-competitive’

- PMLiVE

Biogen spin-out makes first acquisition

Bioverativ attains rare disease group True North

german flag

Germany’s pharma market set for stable growth

Annual growth of 4.9% expected over next four years

How personalising multichannel improves customer experience

You’ve started your multichannel journey, and your customer-facing staff are connecting healthcare professionals to new channels. Great! Providing content in other channels extends customer relationships. Now, with HCP access at...

Anthill Agency

- PMLiVE

Keytruda is first FDA-approved drug for molecular indication

Indicates a significant development in the shift towards personalised medicine

- PMLiVE

Otsuka refiles ‘digital’ medicine for mental illness

Soluble sensor tracks drug ingestion and shares information with HCPs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links